Hubert Metzner

Person

Marburg, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Truncated von Willebrand Factor polypeptides for treating hemophilia
- Patent number 11,814,421
- Issue date Nov 14, 2023
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations of C1 esterase inhibitor
- Patent number 11,554,156
- Issue date Jan 17, 2023
- CSL Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the stability of purified Factor VIII after re...
- Patent number 11,510,968
- Issue date Nov 29, 2022
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein purification and virus inactivation with alkyl glycosides
- Patent number 11,479,578
- Issue date Oct 25, 2022
- CSL BEHRING LENGNAU AG
- Tobias Brandt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for improving the stability of purified Factor VIII after re...
- Patent number 10,881,717
- Issue date Jan 5, 2021
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Truncated von Willebrand factor polypeptides for treating hemophilia
- Patent number 10,688,157
- Issue date Jun 23, 2020
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the stability of purified factor VIII after re...
- Patent number 10,537,616
- Issue date Jan 21, 2020
- CSL Limited
- Carsten Horn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor VIII formulation
- Patent number 10,238,718
- Issue date Mar 26, 2019
- CSL Limited
- Uwe Liebing
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the stability of purified factor VIII after re...
- Patent number 9,956,269
- Issue date May 1, 2018
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent complex of von Willebrand Factor and factor VIII, composit...
- Patent number 9,878,017
- Issue date Jan 30, 2018
- CSL Ltd.
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined use of a sulfated glycosaminoglycan and a hyaluronidase fo...
- Patent number 9,511,123
- Issue date Dec 6, 2016
- CSL Behring GmbH
- Sabine Zollner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of sulfated glycosaminoglycans for improving the bioavailabilit...
- Patent number 9,393,289
- Issue date Jul 19, 2016
- CSL Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the stability of purified factor VIII after re...
- Patent number 9,394,353
- Issue date Jul 19, 2016
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor VIII, von Willebrand factor or complexes thereof with prolon...
- Patent number 9,290,561
- Issue date Mar 22, 2016
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified coagulation factors with prolonged in vivo half-life
- Patent number 8,754,194
- Issue date Jun 17, 2014
- CSL Behring GmbH
- Stefan Schulte
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor VIII, von willebrand factor or complexes thereof with prolon...
- Patent number 8,575,104
- Issue date Nov 5, 2013
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thrombin preparations and process for their production
- Patent number 8,012,728
- Issue date Sep 6, 2011
- CSL Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteolytically cleavable fusion proteins with high molar specific...
- Patent number 7,939,632
- Issue date May 10, 2011
- CSL Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for differentiating between factor XIII deficiency states an...
- Patent number 7,939,288
- Issue date May 10, 2011
- CSL Behring GmbH
- Erhardt Wrabetz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fibrinogen purification
- Patent number 7,550,567
- Issue date Jun 23, 2009
- CSL Behring GmbH
- Hubert Metzner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thrombin preparations and process for their production
- Patent number 7,351,561
- Issue date Apr 1, 2008
- CSL Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tissue glue with improved antiadhesive properties
- Patent number 7,276,235
- Issue date Oct 2, 2007
- ZLB Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Storage-stable, liquid fibrinogen formulation
- Patent number 7,045,601
- Issue date May 16, 2006
- ZLB Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biological sealant storage and dispensing system
- Patent number 6,874,657
- Issue date Apr 5, 2005
- ZLB Behring GmbH
- Hubert J. Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of a hydrogen peroxide plasma sterilization method for the mild...
- Patent number 6,790,410
- Issue date Sep 14, 2004
- Aventis Behring GmbH
- Hubert Metzner
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Grant
Stabilized protein preparations for a tissue adhesive
- Patent number 6,447,774
- Issue date Sep 10, 2002
- Aventis Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transgenic coagulation factor XIII defective animal and its use for...
- Patent number 6,207,877
- Issue date Mar 27, 2001
- Aventis Behring GmbH
- Gerhard Dickneite
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable transglutaminase preparations and processes for their produc...
- Patent number 6,204,036
- Issue date Mar 20, 2001
- Aventis Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO...
- Publication number 20220389082
- Publication date Dec 8, 2022
- CSL Behring Lengnau AG
- Hubert METZNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...
- Publication number 20210308229
- Publication date Oct 7, 2021
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
- Publication number 20200390845
- Publication date Dec 17, 2020
- CSL BEHRING GMBH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN PURIFICATION AND VIRUS INACTIVATION WITH ALKYL GLYCOSIDES
- Publication number 20200317727
- Publication date Oct 8, 2020
- CSL BEHRING LENGNAU AG
- Tobias BRANDT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...
- Publication number 20200268854
- Publication date Aug 27, 2020
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20200095567
- Publication date Mar 26, 2020
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA
- Publication number 20190263890
- Publication date Aug 29, 2019
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
- Publication number 20190175683
- Publication date Jun 13, 2019
- CSL BEHRING GMBH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...
- Publication number 20190038722
- Publication date Feb 7, 2019
- CSL Limited
- Carsten Horn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA
- Publication number 20180161402
- Publication date Jun 14, 2018
- CSL Behring Recombinant Facility AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20180119128
- Publication date May 3, 2018
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COVALENT COMPLEX OF VON WILLEBRAND FACTOR AND FACTOR VIII, COMPOSIT...
- Publication number 20180092966
- Publication date Apr 5, 2018
- CSL Limited
- Hubert METZNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
- Publication number 20180036394
- Publication date Feb 8, 2018
- CSL BEHRING GMBH
- Wolfram SCHAEFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII FORMULATION
- Publication number 20170252412
- Publication date Sep 7, 2017
- CSL Limited
- Uwe LIEBING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVED FACTOR VIII PREPARATIONS SUITABLE FOR THERAPEUTIC USE AND...
- Publication number 20170209546
- Publication date Jul 27, 2017
- CSL BEHRING GMBH
- Stefan SCHMIDBAUER
- G01 - MEASURING TESTING
Information Patent Application
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...
- Publication number 20160367641
- Publication date Dec 22, 2016
- CSL Limited
- Carsten HORN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPLEX
- Publication number 20160200794
- Publication date Jul 14, 2016
- CSL Limited
- Hubert METZNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20160010074
- Publication date Jan 14, 2016
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Combined Use of a Sulfated Glycosaminoglycan and a Hyaluronidase fo...
- Publication number 20150023946
- Publication date Jan 22, 2015
- CSL BEHRING GMBH
- Sabine Zollner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SULFATED GLYCOSAMINOGLYCANS FOR IMPROVING THE BIOAVAILABILIT...
- Publication number 20140315815
- Publication date Oct 23, 2014
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE
- Publication number 20140273096
- Publication date Sep 18, 2014
- CSL BEHRING GMBH
- Stefan SCHULTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY
- Publication number 20140248686
- Publication date Sep 4, 2014
- CSL BEHRING GMBH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for Improving the Stability of Purified Factor VIII After Re...
- Publication number 20140249086
- Publication date Sep 4, 2014
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...
- Publication number 20140072561
- Publication date Mar 13, 2014
- CSL BEHRING GMBH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY
- Publication number 20130337532
- Publication date Dec 19, 2013
- CSL BEHRING GMBH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20110189182
- Publication date Aug 4, 2011
- CSL Behring GmbH
- Hubert METZNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...
- Publication number 20110183907
- Publication date Jul 28, 2011
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Increasing the In Vivo Recovery of Therapeutic Polypeptides
- Publication number 20100222554
- Publication date Sep 2, 2010
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE
- Publication number 20100120664
- Publication date May 13, 2010
- Stefan Schulte
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Proteolytically cleavable fusion proteins with high molar specific...
- Publication number 20090042787
- Publication date Feb 12, 2009
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Hubert Metzner

Person

Patents Grantslast 30 patents

Truncated von Willebrand Factor polypeptides for treating hemophilia

Pharmaceutical formulations of C1 esterase inhibitor

Method for improving the stability of purified Factor VIII after re...

Protein purification and virus inactivation with alkyl glycosides

Method for improving the stability of purified Factor VIII after re...

Truncated von Willebrand factor polypeptides for treating hemophilia

Method for improving the stability of purified factor VIII after re...

Factor VIII formulation

Method for improving the stability of purified factor VIII after re...

Covalent complex of von Willebrand Factor and factor VIII, composit...

Combined use of a sulfated glycosaminoglycan and a hyaluronidase fo...

Use of sulfated glycosaminoglycans for improving the bioavailabilit...

Method for improving the stability of purified factor VIII after re...

Factor VIII, von Willebrand factor or complexes thereof with prolon...

Modified coagulation factors with prolonged in vivo half-life

Factor VIII, von willebrand factor or complexes thereof with prolon...

Thrombin preparations and process for their production

Proteolytically cleavable fusion proteins with high molar specific...

Method for differentiating between factor XIII deficiency states an...

Fibrinogen purification

Thrombin preparations and process for their production

Tissue glue with improved antiadhesive properties

Storage-stable, liquid fibrinogen formulation

Biological sealant storage and dispensing system

Use of a hydrogen peroxide plasma sterilization method for the mild...

Stabilized protein preparations for a tissue adhesive

Transgenic coagulation factor XIII defective animal and its use for...

Stable transglutaminase preparations and processes for their produc...

Patents Applicationslast 30 patents

A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO...

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...

PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR

PROTEIN PURIFICATION AND VIRUS INACTIVATION WITH ALKYL GLYCOSIDES

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA

PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

COVALENT COMPLEX OF VON WILLEBRAND FACTOR AND FACTOR VIII, COMPOSIT...

PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR

FACTOR VIII FORMULATION

IMPROVED FACTOR VIII PREPARATIONS SUITABLE FOR THERAPEUTIC USE AND...

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...

COMPLEX

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

Combined Use of a Sulfated Glycosaminoglycan and a Hyaluronidase fo...

USE OF SULFATED GLYCOSAMINOGLYCANS FOR IMPROVING THE BIOAVAILABILIT...

MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE

THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY

Method for Improving the Stability of Purified Factor VIII After Re...

FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...

THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...

Method of Increasing the In Vivo Recovery of Therapeutic Polypeptides

MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE

Proteolytically cleavable fusion proteins with high molar specific...